By: Brandon M. Macsata, CEO, ADAP Advocacy Association
Last year while attending the Biotechnology Innovation Organization's ("BIO") Patient & Health Advocacy Summit in Washington, DC, an important, but little known patient resource was shared during one of the panel discussions. It involves the U.S. Food & Drug Administration ("FDA") and the ability of patients to and their caregivers ask questions to FDA or to request a meeting.
The Patients Ask FDA is an online portal located at https://www.fda.gov/patients/learn-about-fda-patient-engagement/patients-ask-fda.
This innovative, patient-center resource makes available information about ongoing initiatives on how to engage with the FDA, testimonials from FDA patient representatives, as well as how to apply to the FDA Patient Representative Program. It also includes current FDA Patient Listening Sessions, which are in partnership with the National Organization for Rare Disorders ("NORD").
The ADAP Advocacy Association places a premium on patient engagement and we encourages to use this important tool afforded to them by the FDA.
Disclaimer: Guest blogs do not necessarily reflect the views of the ADAP Advocacy Association, but rather they provide a neutral platform whereby the author serves to promote open, honest discussion about public health-related issues and updates.
No comments:
Post a Comment